Yu-Jhen Cheng
Overview
Explore the profile of Yu-Jhen Cheng including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
179
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yang C, Shen K, Ho H, Huang C, Cheng Y, Pu C, et al.
Mol Ther Nucleic Acids
. 2024 Jul;
35(3):102261.
PMID: 39071950
Successful DNA vaccination generally requires the aid of either a viral vector within vaccine components or an electroporation device into the muscle or skin of the host. However, these systems...
2.
Screening and identification of emodin as an EBV DNase inhibitor to prevent its biological functions
Wu C, Chen M, Lee T, Cheng Y, Tsou H, Huang T, et al.
Virol J
. 2023 Jul;
20(1):148.
PMID: 37443068
Background: The Epstein-Barr virus (EBV) is a prevalent oncovirus associated with a variety of human illnesses. BGLF5, an EBV DNase with alkaline nuclease (AN) activity, plays important roles in the...
3.
Wu C, Lee T, Cheng Y, Cho D, Chen J
Molecules
. 2022 Dec;
27(23).
PMID: 36500249
Kaempferol (KP, 3,4',5,7-tetrahydroxyflavone), a dietary flavonol, has anti-cancer, antioxidant, anti-inflammatory, antimicrobial, and antimutagenic functions. However, it is unknown whether kaempferol possesses anti-Epstein-Barr virus (EBV) activity. Previously, we demonstrated that inhibition...
4.
Lin C, Ho H, Venkatesan P, Huang C, Cheng Y, Lin Y, et al.
Pharmaceutics
. 2021 Oct;
13(10).
PMID: 34683862
Clinical cases of allergic reaction that are due to excipients containing polyethylene glycol (PEG), a hydrophilic molecule commonly used in drug/vaccine formulations, has attracted much attention in recent years. In...
5.
Ho H, Huang C, Cheng Y, Shen K, Tzeng T, Liu S, et al.
Int J Pharm
. 2021 Aug;
607:121024.
PMID: 34416331
Vaccination is regarded as the most effective intervention for controlling the coronavirus disease 2019 (COVID-19) pandemic. The objective of this study is to provide comprehensive information on lipid squalene nanoparticle...
6.
Ho H, Huang C, Cheng Y, Chen I, Liu S, Huang C, et al.
Biomed Pharmacother
. 2021 Jun;
141:111799.
PMID: 34098215
This study describes the assessment of mucosal adjuvant activity of a squalene-based nanoemulsion (SQ@NE) following intravaginal delivery in mice. After immunization, a high level of recruitment of CD11b/c granulocytes and...
7.
Cheng Y, Huang C, Ho H, Huang M
Colloids Surf A Physicochem Eng Asp
. 2020 Sep;
608:125564.
PMID: 32929307
Aluminum-containing salts are commonly used as antacids and vaccine adjuvants; however, key features of functional activities remain unclear. Here, we characterized vaccine formulations based on aluminum phosphate and aluminum hydroxide...
8.
Wu C, Chen M, Cheng Y, Ko Y, Lin S, Chiu I, et al.
Cancers (Basel)
. 2019 Nov;
11(11).
PMID: 31731581
Nasopharyngeal carcinoma (NPC) is a unique malignancy derived from the epithelium of the nasopharynx. Despite great advances in the development of radiotherapy and chemotherapy, relapse and metastasis in NPC patients...
9.
Huang S, Wu C, Cheng Y, Chou S, Jiang Y, Chu K, et al.
Oncotarget
. 2017 Nov;
8(45):78948-78964.
PMID: 29108278
Nasopharyngeal carcinoma (NPC) is a serious health problem in China and Southeast Asia. Relapse is the major cause of mortality, but mechanisms of relapse are mysterious. Epstein-Barr virus (EBV) reactivation...
10.
Wu C, Fang C, Cheng Y, Hsu H, Chou S, Huang S, et al.
J Biomed Sci
. 2017 Jan;
24(1):2.
PMID: 28056971
Background: Lytic reactivation of EBV has been reported to play an important role in human diseases, including NPC carcinogenesis. Inhibition of EBV reactivation is considered to be of great benefit...